A Novel Phenotypic Drug Susceptibility Assay for Human Immunodeficiency Virus Type 1

Although combination antiretroviral therapy has resulted in a considerable improvement in the treatment of human immunodeficiency virus (HIV) type 1 (HIV-1) infection, the emergence of resistant virus is a significant obstacle to the effective management of HIV infection and AIDS. We have developed...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Petropoulos, Christos J., Parkin, Neil T., Limoli, Kay L., Lie, Yolanda S., Wrin, Terri, Huang, Wei, Tian, Huan, Smith, Douglas, Winslow, Genine A., Capon, Daniel J., Whitcomb, Jeannette M.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2000
Assuntos:	Antiviral Agents
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC89793/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10722492/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.44.4.920-928.2000
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!